Apnoeic oxygenation during intubation is used to prevent desaturation during intubation. The aim of this review was to assess whether apnoeic oxygenation during endotracheal intubation reduced the incidence of hypoxaemia. Five major databases were systematically searched for all relevant studies published up to May 2016. All study designs with a control group and a group receiving apnoeic oxygenation were included in this review. These studies were then assessed for level of evidence and risk of bias. The data were then analysed using a meta-analysis. Eleven studies (six high quality randomised controlled trials, four low quality level two studies and one low quality level three study) were found. In the meta-analysis there was strong evidence for benefit of apnoeic oxygenation in terms of improved SpO 2 in elective surgical patients, obese patients and those undergoing emergency intubation without respiratory failure. However, no significant benefit was found in patients with respiratory failure. This is the first meta-analysis to be performed on apnoeic oxygenation during intubation. Apnoeic oxygenation provides significant benefit in terms of improving SpO 2 for the majority of intubations, although there appears to be no benefit in patients whose indication for intubation is respiratory failure. Apnoeic oxygenation ought to be considered for integration into intubation protocols.
Introduction
Endotracheal intubation is a common life-saving procedure performed in the operating theatre, intensive care unit and emergency department 1 . However, in certain circumstances intubation has the potential to be a high risk procedure, particularly when performed outside of the operating theatre 1, 2 . The most significant complication commonly associated with endotracheal intubation is hypoxaemia 1, 3 , which in critically ill patients is strongly associated with cardiac arrest and death 3 . Pre-oxygenation prior to intubation can prolong time to desaturation, or 'safe apnoea time' 1 . However, this is significantly less effective in the critically ill population 4 . With this in mind several strategies to prevent hypoxia during endotracheal intubation have been investigated.
One such strategy is apnoeic oxygenation, which was first reported in 1959 5 . During intubation or any period of apnoea, oxygen may be provided via nasal cannulae to facilitate continuous oxygenation. The mechanism of prolonged oxygenation is thought to be the mass diffusion of gas from the pharynx into the alveoli as oxygen diffuses into the blood, with the main prerequisites being a patent upper airway and an absence of pulmonary shunting 6, 7 .
To date there have been several studies including a number of level one randomised controlled trials (RCTs) investigating the use of apnoeic oxygenation during intubation but no systematic reviews or meta-analyses have yet been conducted. The aim of this review was to investigate whether apnoeic oxygenation during endotracheal intubation reduces the incidence of hypoxaemia during intubation.
Methods

Search strategy
Five databases (CINAHL, SCOPUS, PubMed, Medline and Web of Science) were systematically searched up until May 2016. Two independent reviewers (LDW & LKW) searched the databases using the terms (1) (apnoeic oxygenation) AND (endotracheal intubation); (2) (apneic oxygenation) AND (endotracheal intubation). A manual reference check of recent papers was then performed to identify any additional studies.
Inclusion criteria
For a study to be included, the study was required to compare apnoeic oxygenation during intubation to a control group. Two reviewers (LDW & LKW) assessed each study for inclusion in this systematic review. All study designs were eligible for inclusion.
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Data extraction
Data were extracted from each article that met the inclusion criteria. The data extracted from each study included the indication for intubation, apnoeic oxygenation intervention and clinical outcome results. The data collected by each reviewer were then assessed for homogeneity.
Definition(s)
Apnoeic oxygenation: oxygen delivered via nasal cannulae at flow rates of five to 60 litres per minute during the period of intubation.
Successful apnoeic oxygenation: different methods were used to measure desaturation during intubation with and without apnoeic oxygenation. For the purpose of this review successful apnoeic oxygenation was defined as any one or more of; increased post-apnoeic PaO 2 , increased minimum recorded SpO 2 , reduced incidence of SpO 2 <80%, or a prolonged safe apnoea time (as defined by each study's authors).
Level of evidence, risk of bias and outcome level of evidence ranking
The Centre for Evidence Based Medicine (CEBM): Levels of Evidence Introduction Document was then used to evaluate each article 8 . The Cochrane Collaboration's tool for assessing the risk of bias was used, with each study given a quality score 9, 10 . Outcomes were then grouped together and given a level of evidence ranking based on the collective strength of evidence 9,10 : 1. Strong evidence: two or more high quality (quality score ≥4) RCTs with ≥75% consistency in findings. 2. Moderate evidence: one high quality RCT and two or more low quality studies with ≥75% consistency in findings.
Weak evidence: one high quality RCT or multiple low
quality studies with ≥75% consistency in findings.
Conflicting evidence: multiple low and/or high quality
studies with ≤75% consistency in findings. 5. No evidence: no studies could be found, may include technique reports.
Statistical analyses
The combined data were analysed using RevMan 5.3 software (The Nordic Cochrane Centre, Copenhagen, Denmark). The relative risk (RR) with 95% confidence interval (CI) was calculated for dichotomous outcomes, and the weighted mean difference (WMD) with 95% CI for continuous outcomes. The Mantel-Haenszel (M-H) random effects model was used. Heterogeneity was assessed using the chisquared and I 2 statistic, with an I 2 >50% indicating significant heterogeneity. A P value of <0.05 provided evidence of significant RR or WMD. 
Results
Literature search results
The systematic literature search yielded 1,808 citations. Of these 1,808 citations, 907 duplicates were removed. Fortyfive article abstracts were retrieved for review based on their title mentioning apnoeic oxygenation and intubation. Of the 45 abstracts reviewed, 15 mentioned apnoeic oxygenation during intubation; the full text of these articles was reviewed. Of the 15 articles, 11 met the inclusion criteria, i.e. intubations were performed with both a control group (no apnoeic oxygenation) and an intervention group (apnoeic oxygenation during intubation) ( Figure 1 ). These eleven studies included 2,078 patients (Table 1) . Each study was then screened for risk of bias and methodological quality using the Cochrane Collaboration's tool for assessing the risk of bias ( Table 2) . Of these eleven studies, six were high quality level one RCTs, four were low quality level two studies and one was a low quality level three study (Tables 1 and 2) .
Improved oxygenation during intubation
Successful apnoeic oxygenation was assessed qualitatively. Overall, there was conflicting evidence in support of apnoeic oxygenation. Of the eleven studies, eight showed significant improvement. The remaining three studies by Dyett et al, Semler et al, and Vourc'h et al showed no significant benefit in hypoxic respiratory failure patients. 
Meta-analysis
Strong evidence was found for the use of apnoeic oxygenation to prevent desaturation. Six studies (three high and three low quality) assessed the effect of apnoeic oxygenation on the occurrence of desaturation during intubation [2] [3] [4] 7, 11, 12 . All six studies demonstrated a reduction in the occurrence of desaturation during intubation with apnoeic oxygenation (Figure 2 ). Overall, there was a significant reduction in the rate of desaturation (RR 0.65, 95% CI 0.50-0.86, P=0.005) with acceptable heterogeneity (I 2 = 49%).
Strong evidence was found for increased safe apnoea time with apnoeic oxygenation. Three high level studies assessed this outcome 7, 13, 14 , all showing a beneficial effect with apnoeic oxygenation (WMD +1.88 minutes, 95% CI 1.37-2.39, P <0.00001; Figure 3 ). There was significant heterogeneity in regard to the magnitude of effect (I 2 = 63%).
Strong evidence was also found for the effect of apnoeic oxygenation on the minimum recorded SpO 2 during intubation. Three studies (two high and one low quality) showed a significant benefit associated with apnoeic oxygenation, increasing the minimum recorded SpO 2 by 2%-6.6%. (WMD +2.17% SpO 2 , 95% CI 1.14-3.21, P <0.0001) with acceptable heterogeneity (I 2 = 32%; Figure 4 ) 4,7,15 .
Although not statistically significant, the risk of desaturation to an SpO 2 <80% more than halved (RR 0.43, 95% CI 0.18-1.04, P=0.06) 11, 12 and there was a significant difference in first-pass intubation success (RR 1.06, 95% CI 1.02-1.11, P=0.005) 3, 4, 11, 12 . There was no significant difference in duration of ventilation in the intensive care unit with apnoeic oxygenation (RR -1.97, 95% CI -5.89-1.95, P=0.32) 12, 15 . Apnoeic oxygenation improved PaO 2 at 3-4.5 minutes of apnoea (mean difference 84.12, 95% CI 47.22-121.02; P <0.0001) 16, 17 and reduced re-saturation time (mean difference -66.55, 95% CI -95.10--38.01, P <0.05) 3, 7 .
Discussion
We undertook a systematic review and meta-analysis of studies comparing apnoeic oxygenation via nasal cannulae with a control group to extend the work done by authors of previous qualitative reviews. To our knowledge this is the first Our meta-analysis supports the conclusion that apnoeic oxygenation during intubation is associated with a reduced risk of desaturation (RR 0.65, P=0.005) with consistent effects across all six studies (I 2 = 49%). This is likely to be of clinical significance; desaturation is a common complication of intubation and even brief episodes have been associated with morbidity and mortality 1, 3, 11, 18 . There was variation in the definition of desaturation among different studies, which reflects regionally prevalent norms; North American studies tended to report desaturations below 90% SpO 2 , whilst European studies tended to be more conservative at ~93% SpO 2 3 . Apnoeic oxygenation was associated with a higher minimum SpO 2 during intubation of +2.17% WMD (95% CI 1. 14-3.35 ). The three studies reporting on this outcome reported a mean minimum SpO 2 of 87.7%-90%. Once SpO 2 begins to fall to 90% or below, PaO 2 begins to rapidly decline as defined by the shape of the haemoglobinoxygen dissociation curve 1 ; these modest mean changes in peripheral oxygen saturation may therefore reflect significant physiological changes with clinical implications.
Screening of bias and methodological quality based on the Cochrane Collaboration's tool for assessing the risk of bias
We found strong evidence that apnoeic oxygenation is associated with prolonging the safe apnoea time by 1.4-2.4 minutes (WMD 1.88 minutes). This is likely to be significant in clinical practice as the amount of time available for intubation prior to desaturation is a critical determinant of patient safety 1 .
Our review included data from a broad range of patient subgroups, from elective surgical patients to out-of-hospital emergency intubations. Some patient groups are more prone to early desaturation 7, 15 whilst others may be more sensitive to the effects of a low PaO 2 11 . Papers included in this review showed strong evidence for improvements associated with apnoeic oxygenation in elective surgical intubations, including subgroups who are at higher risk during elective intubation such as obese patients.
Critically ill patients undergoing emergency intubation are at particularly high risk of adverse outcomes 1 . This is multifactorial, but may be a result of increased baseline oxygen requirements associated with illness, underlying cardiac disease or primary pulmonary pathology causing respiratory compromise. Pre-oxygenation is less effective in acutely ill patients and adjuncts that minimise the risk of desaturation may be of particular benefit in these settings 1, 11 .
While some have advocated for the adoption of apnoeic oxygenation as standard practice in emergency intubations 1 , others have focused on the conflicting evidence surrounding the use of apnoeic oxygenation in critically ill patients 2,4,11 . In this review the two small high quality RCTs and one level two study showed no significant benefit in this subgroup of patients even when using high flow rates, while the three larger albeit lower quality studies that included critically ill patients within their study populations demonstrated beneficial effects. Whilst this may appear conflicting, other authors have previously highlighted the clear differences amongst the studies' populations.
Semler et al and Vourc'h et al's RCTs were largely composed of patients undergoing intubation for respiratory failure, many of whom received non-invasive ventilation either prior to intubation or during a modified rapid sequence induction. When the indication for intubation is hypoxic respiratory failure, it would seem apnoeic oxygenation is of little or no benefit. This is in keeping with our understanding of the physiology of apnoeic oxygenation; these patients are likely to have developed severe pulmonary circulatory shunting, rendering passive ventilation ineffective 11 .
Of the larger low quality papers examining emergency intubations, one focused on all unplanned intubations within a large hospital 2 , two were from the same emergency department population 4, 11 , and a fourth was of patients intubated by a helicopter retrieval service 3 . The divergent cohorts highlight the broad range of indications for emergency intubation in hospital, a minority of which are for respiratory failure 2, 4 . As such we found these studies have greater external validity relating to intubation in general, beyond highly specialised intubation environments such as the intensive care unit, which may have a high proportion of respiratory failure patients. There is strong evidence to suggest a benefit in providing apnoeic oxygenation during the majority of emergency intubations.
There was a suggestion of a reduction in the number of 'critical desaturations' (SpO 2 <80%), with a RR reduction of 43%, but this did not reach statistical significance (95% CI 0.18-1.04, P=0.06).
Limitations
There was moderate heterogeneity among the studies included in this review. There was substantial clinical variability, with divergent patient groups and variation in the interventional flow rates used (5-60 l/minute). We chose to prioritise external validity and applicability of this review by including these heterogeneous papers, given that it is the first systematic review of these results. The majority of the current literature is centred around low to intermediate flow rate apnoeic oxygenation during intubation.
The optimal flow rate for standard nasal cannulae is controversial; Sakles et al 4 noted that clinicians frequently chose to oxygenate at 5 l/minute during intubation, despite guidelines suggesting 15 l/minute 1 . They hypothesised that clinicians are reticent to exceed the flow rates commonly used in hospital (≤5 l/minute), despite prior studies showing excellent tolerance of high flow rates in volunteers 4 . Of course potential discomfort caused by high flow rates should not be of consequence in the anaesthetised patient.
There was a very small but statistically significant difference in the first-pass intubation attempt rate in favour of the intervention group (RR 1.06, 95% CI 1.02-1.11). Given the potential for allocation bias in some papers, this may reflect that there were more patients with difficult airways in the control group. However this is not supported by the duration of ventilation data, which showed no significant differences between groups.
Many of the studies involving emergency intubation were observational, some of which were included. Performing high quality RCTs in emergency situations can be challenging, particularly when attempting to capture events that occur in a range of hospital departments. There are various limitations with this review that we were not able to compensate for in our methods. All 11 studies used a surrogate measure as a primary outcome and only three of eleven papers also looked at firm patient outcomes (two level one and one level three). Many papers used SpO 2 measures as outcomes; whilst we have discussed evidence that SpO 2 is associated with poorer outcomes and there is a highly plausible physiological explanation for potential benefits of apnoeic oxygenation, studies to date do not link apnoeic oxygenation to improved long-term outcomes. Where feasible, future studies could add to our knowledge by including firm outcome measures such as cardiac arrest, duration of ventilation, incidence of hypoxic brain injury and mortality. It is also worth noting that the pooled results in this review are from several small studies. Therefore the results are likely to be fragile and new studies may alter or even completely change the conclusions of this paper. Thus even though several outcome measures have demonstrated strong evidence, caution is advised when applying it to clinical guidelines and practice.
Conclusion
Apnoeic oxygenation during intubation is a simple intervention, utilising readily available equipment, and can be easily introduced. There is strong evidence to suggest its use reduces the incidence of oxygen desaturation during both routine and emergency intubations. In the minority of patients who are hypoxaemic prior to intubation, or have respiratory failure, it is unlikely to be of significant benefit. Given the potential benefits, routine use of apnoeic oxygenation by standard nasal cannulae at flow rates up to 15 l/minute should be considered for integration into all intubation plans. However, there is not yet enough data available to advise a specific flow rate for the purpose of apnoeic oxygenation during intubation.
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